Inducible and reversible RNA N6-methyladenosine editing

RNA modifications, including N 6 -methyladenosine (m 6 A), have been reported to regulate fundamental RNA processes and properties, and directly linked to various human diseases. Methods enabling temporal and transcript/locus-specific editing of specific RNA modifications are essential, but still li...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 13; no. 1; p. 1958
Main Authors Shi, Huaxia, Xu, Ying, Tian, Na, Yang, Ming, Liang, Fu-Sen
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 12.04.2022
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:RNA modifications, including N 6 -methyladenosine (m 6 A), have been reported to regulate fundamental RNA processes and properties, and directly linked to various human diseases. Methods enabling temporal and transcript/locus-specific editing of specific RNA modifications are essential, but still limited, to dissect the dynamic and context-dependent functions of these epigenetic modifications. Here, we develop a chemically inducible and reversible RNA m 6 A modification editing platform integrating chemically induced proximity (CIP) and CRISPR methods. We show that m 6 A editing can be temporally controlled at specific sites of individual RNA transcripts by the addition or removal of the CIP inducer, abscisic acid (ABA), in the system. By incorporating a photo-caged ABA, a light-controlled version of m 6 A editing platform can be developed. We expect that this platform and strategy can be generally applied to edit other RNA modifications in addition to m 6 A. RNA modifications, including N6-methyladenosine (m6A), have been reported to regulate fundamental RNA processes and properties, and directly linked to various human diseases. Here, the authors develop a chemically inducible and reversible RNA m6A modification editing platform integrating chemically induced proximity (CIP) and CRISPR methods.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2041-1723
2041-1723
DOI:10.1038/s41467-022-29665-y